Literature DB >> 10222299

Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients.

J Lehrner1, R Kalchmayr, W Serles, A Olbrich, E Pataraia, S Aull, J Bacher, F Leutmezer, G Gröppel, L Deecke, C Baumgartner.   

Abstract

We determined the interrelations of chronological age, age at seizure onset, duration of seizure disorder, cognitive functioning (IQ), scales of activities of daily living, depressive mood disorder and measures of health-related quality of life (HRQOL). Furthermore, we investigated the association of the laterality of seizure onset zone and absence/presence of hippocampal atrophy and/or sclerosis (HA/HS) with measures of HRQOL, activities of daily living (ADL) and depressive mood disorder. In the setting of pre-surgical epilepsy evaluation, a sample of 56 patients with temporal lobe epilepsy (TLE) was studied using the Bonner Skalen für Epilepsie (BPSE) and the depression inventory D-S of von Zerssen. Patients reported high levels of dependency on others and poor coping capabilities. Our data also showed specific ADL-behaviour suggesting social withdrawal and isolation. Our results indicate emotional impairment as a major problem in TLE, because 45% of our patients scored in the depressive range of the D-S depression scale. Depression score was found to be a powerful predictor of self-reported quality of life after adjusting for seizure-related variables, demographic variables and cognitive functioning (IQ). The only scale showing a significant laterality effect was ADL-home. No relationship between the dependent measures of HRQOL, ADL-social, ADL-cultural, depressive mood disorder and laterality of the epileptogenic zone or absence/presence of HA/HS was found. HRQOL and depressive mood disorder are strongly interrelated indicating that patients with depressive symptoms report lower quality of life and specific patterns of ADL. HRQOL, ADL and depressive mood disorder are largely independent of biological markers such as laterality of seizure onset zone and absence/presence of HA/HS in TLE. Copyright 1999 British Epilepsy Association.

Entities:  

Mesh:

Year:  1999        PMID: 10222299     DOI: 10.1053/seiz.1999.0272

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  21 in total

1.  Depression in Epilepsy Is Much More Than a Reactive Process.

Authors:  Andres M. Kanner
Journal:  Epilepsy Curr       Date:  2003-11       Impact factor: 7.500

2.  Self-Esteem, Social Phobia and Depression Status in Patients with Epilepsy.

Authors:  Ayşe Kutlu; Gökçen Gökçe; Ülkü Büyükburgaz; Macit Selekler; Sezer KOMŞUOğLU
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

3.  Beyond depression: The impact of executive functioning on quality of life in patients with temporal lobe epilepsy.

Authors:  Tobin Ehrlich; Anny Reyes; Brianna M Paul; Vedang Uttarwar; Stephen Hartman; Kushagra Mathur; Yu-Hsuan A Chang; Manu Hegde; Jerry J Shih; Carrie R McDonald
Journal:  Epilepsy Res       Date:  2018-11-13       Impact factor: 3.045

Review 4.  Quality of life in patients with epilepsy and impact of treatments.

Authors:  Patrizia Berto
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

5.  Depression and epilepsy: a new perspective on two closely related disorders.

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2006 Sep-Oct       Impact factor: 7.500

Review 6.  Depression and epilepsy: do glucocorticoids and glutamate explain their relationship?

Authors:  Andres M Kanner
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

7.  Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study.

Authors:  A Lothe; A Didelot; A Hammers; N Costes; M Saoud; F Gilliam; P Ryvlin
Journal:  Brain       Date:  2008-09-02       Impact factor: 13.501

Review 8.  Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs.

Authors:  J Mitchell Miller; Robert P Kustra; Alain Vuong; Anne E Hammer; John A Messenheimer
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Passive Radar for Opportunistic Monitoring in E-Health Applications.

Authors:  Wenda Li; Bo Tan; Robert Piechocki
Journal:  IEEE J Transl Eng Health Med       Date:  2018-01-25       Impact factor: 3.316

10.  Psychometric properties of Bengali version of QOLIE-10 in epileptic patients.

Authors:  Sagar Basu; Debasish Sanyal; Malay Ghosal; Biman Roy; A K Senapati; S K Das
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.